Expanding the HLP’s Presence Beyond Its Existing Michigan and New York Locations, Daniel B. Brown Opens The Health Law Partners’ Atlanta Office

Wi-Fi Drives Adoption as Healthcare Organizations Around the World Improve Efficiency, Compliance and Patient Care Using Existing Wi-Fi Infrastructures

LONDON, UNITED KINGDOM–(Marketwire – Sept. 2, 2010) – Allocate Software Plc, the leading provider of workforce optimisation and electronic rostering solutions appointed Beyond the Deal to deliver pre-deal integration support and planning in their acquisition of Time Care AB, a leading Swedish-based provider of workforce management software with a strong focus on the healthcare market. 

SAINT LAURENT, QUEBEC–(Marketwire – Sept. 2, 2010) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCBB:IGXT) (“IntelGenx”) today announced the completion of a pilot study that indicates that IntelGenx has successfully developed a novel oral film, INT007, that is bioequivalent to a leading branded tablet containing a phosphodiesterase type 5 (PDE-5) inhibitor for the treatment of erectile dysfunction. INT007 has been developed using IntelGenx’ proprietary immediate release “VersaFilm” drug delivery technology.

Continues to Open SmileShoppes

Wi-Fi Drives Adoption as Healthcare Organizations Around the World Improve Efficiency, Compliance and Patient Care Using Existing Wi-Fi Infrastructures

Wi-Fi Drives Adoption as Healthcare Organizations Around the World Improve Efficiency, Compliance and Patient Care Using Existing Wi-Fi Infrastructures

DALLAS, TX–(Marketwire – September 2, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) announced today shareholder points of interest discussed during the Company’s nationwide teleconference yesterday. Mr. Bryan A. Scott, President & CEO, and Mr. Brian Hart, COO of Metiscan, provided deeper insight into its subsidiaries’ markets, products, and near term objectives, as well as Metiscan’s pursuit in listing on the OTCBB.

DALLAS, TX–(Marketwire – September 2, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) announced today shareholder points of interest discussed during the Company’s nationwide teleconference yesterday. Mr. Bryan A. Scott, President & CEO, and Mr. Brian Hart, COO of Metiscan, provided deeper insight into its subsidiaries’ markets, products, and near term objectives, as well as Metiscan’s pursuit in listing on the OTCBB.

LONDON–(Marketwire – September 2, 2010) –  Genome Research Group (GRG) (PINKSHEETS: KKUR) recently announced its intended merger with ChromoCure, Inc. and consolidation of the operations and technologies of both groups. Genome Research Group personnel have assumed all executive and board duties and have no current or planned operations in the USA.